268 related articles for article (PubMed ID: 19166313)
1. Two distinct motifs within the p53 transactivation domain bind to the Taz2 domain of p300 and are differentially affected by phosphorylation.
Jenkins LM; Yamaguchi H; Hayashi R; Cherry S; Tropea JE; Miller M; Wlodawer A; Appella E; Mazur SJ
Biochemistry; 2009 Feb; 48(6):1244-55. PubMed ID: 19166313
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the p300 Taz2-p53 TAD2 complex and comparison with the p300 Taz2-p53 TAD1 complex.
Miller Jenkins LM; Feng H; Durell SR; Tagad HD; Mazur SJ; Tropea JE; Bai Y; Appella E
Biochemistry; 2015 Mar; 54(11):2001-10. PubMed ID: 25753752
[TBL] [Abstract][Full Text] [Related]
3. Four domains of p300 each bind tightly to a sequence spanning both transactivation subdomains of p53.
Teufel DP; Freund SM; Bycroft M; Fersht AR
Proc Natl Acad Sci U S A; 2007 Apr; 104(17):7009-14. PubMed ID: 17438265
[TBL] [Abstract][Full Text] [Related]
4. Structural basis for p300 Taz2-p53 TAD1 binding and modulation by phosphorylation.
Feng H; Jenkins LM; Durell SR; Hayashi R; Mazur SJ; Cherry S; Tropea JE; Miller M; Wlodawer A; Appella E; Bai Y
Structure; 2009 Feb; 17(2):202-10. PubMed ID: 19217391
[TBL] [Abstract][Full Text] [Related]
5. Cooperative regulation of p53 by modulation of ternary complex formation with CBP/p300 and HDM2.
Ferreon JC; Lee CW; Arai M; Martinez-Yamout MA; Dyson HJ; Wright PE
Proc Natl Acad Sci U S A; 2009 Apr; 106(16):6591-6. PubMed ID: 19357310
[TBL] [Abstract][Full Text] [Related]
6. Structural insights into TAZ2 domain-mediated CBP/p300 recruitment by transactivation domain 1 of the lymphopoietic transcription factor E2A.
Lochhead MR; Brown AD; Kirlin AC; Chitayat S; Munro K; Findlay JE; Baillie GS; LeBrun DP; Langelaan DN; Smith SP
J Biol Chem; 2020 Mar; 295(13):4303-4315. PubMed ID: 32098872
[TBL] [Abstract][Full Text] [Related]
7. Molecular basis of the interactions between the p73 N terminus and p300: effects on transactivation and modulation by phosphorylation.
Burge S; Teufel DP; Townsley FM; Freund SM; Bycroft M; Fersht AR
Proc Natl Acad Sci U S A; 2009 Mar; 106(9):3142-7. PubMed ID: 19218448
[TBL] [Abstract][Full Text] [Related]
8. The high-risk HPV16 E7 oncoprotein mediates interaction between the transcriptional coactivator CBP and the retinoblastoma protein pRb.
Jansma AL; Martinez-Yamout MA; Liao R; Sun P; Dyson HJ; Wright PE
J Mol Biol; 2014 Dec; 426(24):4030-4048. PubMed ID: 25451029
[TBL] [Abstract][Full Text] [Related]
9. Regulation of the Activity in the p53 Family Depends on the Organization of the Transactivation Domain.
Krauskopf K; Gebel J; Kazemi S; Tuppi M; Löhr F; Schäfer B; Koch J; Güntert P; Dötsch V; Kehrloesser S
Structure; 2018 Aug; 26(8):1091-1100.e4. PubMed ID: 30099987
[TBL] [Abstract][Full Text] [Related]
10. Graded enhancement of p53 binding to CREB-binding protein (CBP) by multisite phosphorylation.
Lee CW; Ferreon JC; Ferreon AC; Arai M; Wright PE
Proc Natl Acad Sci U S A; 2010 Nov; 107(45):19290-5. PubMed ID: 20962272
[TBL] [Abstract][Full Text] [Related]
11. Mapping the interactions of the p53 transactivation domain with the KIX domain of CBP.
Lee CW; Arai M; Martinez-Yamout MA; Dyson HJ; Wright PE
Biochemistry; 2009 Mar; 48(10):2115-24. PubMed ID: 19220000
[TBL] [Abstract][Full Text] [Related]
12. Solution structure of the TAZ2 (CH3) domain of the transcriptional adaptor protein CBP.
De Guzman RN; Liu HY; Martinez-Yamout M; Dyson HJ; Wright PE
J Mol Biol; 2000 Oct; 303(2):243-53. PubMed ID: 11023789
[TBL] [Abstract][Full Text] [Related]
13. Interaction of the transactivation domain of B-Myb with the TAZ2 domain of the coactivator p300: molecular features and properties of the complex.
Oka O; Waters LC; Strong SL; Dosanjh NS; Veverka V; Muskett FW; Renshaw PS; Klempnauer KH; Carr MD
PLoS One; 2012; 7(12):e52906. PubMed ID: 23300815
[TBL] [Abstract][Full Text] [Related]
14. Regulation by phosphorylation of the relative affinities of the N-terminal transactivation domains of p53 for p300 domains and Mdm2.
Teufel DP; Bycroft M; Fersht AR
Oncogene; 2009 May; 28(20):2112-8. PubMed ID: 19363523
[TBL] [Abstract][Full Text] [Related]
15. S100A6 competes with the TAZ2 domain of p300 for binding to p53 and attenuates p53 acetylation.
Graczyk A; Słomnicki LP; Leśniak W
J Mol Biol; 2013 Sep; 425(18):3488-94. PubMed ID: 23796514
[TBL] [Abstract][Full Text] [Related]
16. Structural basis for subversion of cellular control mechanisms by the adenoviral E1A oncoprotein.
Ferreon JC; Martinez-Yamout MA; Dyson HJ; Wright PE
Proc Natl Acad Sci U S A; 2009 Aug; 106(32):13260-5. PubMed ID: 19651603
[TBL] [Abstract][Full Text] [Related]
17. Recognition of the disordered p53 transactivation domain by the transcriptional adapter zinc finger domains of CREB-binding protein.
Krois AS; Ferreon JC; Martinez-Yamout MA; Dyson HJ; Wright PE
Proc Natl Acad Sci U S A; 2016 Mar; 113(13):E1853-62. PubMed ID: 26976603
[TBL] [Abstract][Full Text] [Related]
18. Structure of the Taz2 domain of p300: insights into ligand binding.
Miller M; Dauter Z; Cherry S; Tropea JE; Wlodawer A
Acta Crystallogr D Biol Crystallogr; 2009 Dec; 65(Pt 12):1301-8. PubMed ID: 19966416
[TBL] [Abstract][Full Text] [Related]
19. Phosphorylation Regulates the Bound Structure of an Intrinsically Disordered Protein: The p53-TAZ2 Case.
Ithuralde RE; Turjanski AG
PLoS One; 2016; 11(1):e0144284. PubMed ID: 26742101
[TBL] [Abstract][Full Text] [Related]
20. Structures of KIX domain of CBP in complex with two FOXO3a transactivation domains reveal promiscuity and plasticity in coactivator recruitment.
Wang F; Marshall CB; Yamamoto K; Li GY; Gasmi-Seabrook GM; Okada H; Mak TW; Ikura M
Proc Natl Acad Sci U S A; 2012 Apr; 109(16):6078-83. PubMed ID: 22474372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
